SHREE GANESH REMEDIES
Back to Cashflow Statement
|
SHREE GANESH REMEDIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹31 Cr | ₹30 Cr | ₹4.59 Cr | ₹-5.22 Cr |
What is the latest Cash Flow from Operating Activities ratio of SHREE GANESH REMEDIES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹31 Cr |
| Mar2024 | ₹30 Cr |
| Mar2020 | ₹4.59 Cr |
| Mar2019 | ₹-5.22 Cr |
How is Cash Flow from Operating Activities of SHREE GANESH REMEDIES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹31 Cr | 0.71 | |
| Mar2024 | ₹30 Cr | 563.81 | |
| Mar2020 | ₹4.59 Cr | Positive | |
| Mar2019 | ₹-5.22 Cr | - | |
Compare Cash Flow from Operating Activities of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹643.8 Cr | 10.9% | 14.1% | -41.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹410,442.0 Cr | 0.5% | -1.5% | -2.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,878.0 Cr | 5.5% | -0.2% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹137,301.0 Cr | 2.1% | 2.8% | 30.9% | Stock Analytics | |
| CIPLA | ₹109,030.0 Cr | 1.3% | -7.9% | -6.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,023.0 Cr | 2% | 4.5% | 2.3% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | 10.9% |
14.1% |
-41.7% |
| SENSEX | 0.5% |
0.8% |
7.2% |
You may also like the below Video Courses